Home Applications 021518 Application 021518
Type NDA
Sponsor ASTELLAS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VESICARE SOLIFENACIN SUCCINATE TABLET;ORAL 5MG Yes No 002 VESICARE SOLIFENACIN SUCCINATE TABLET;ORAL 10MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021518-001 VESICARE SOLIFENACIN SUCCINATE 5MG TABLET / ORAL RLD 2004-11-19 N021518-002 VESICARE SOLIFENACIN SUCCINATE 10MG TABLET / ORAL RLD 2004-11-19
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021518-001 VESICARE 5MG TABLET / ORAL RLD 2004-11-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021518-002 VESICARE 10MG TABLET / ORAL RLD 2004-11-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021518-001 VESICARE 5MG TABLET / ORAL AB RLD 2004-11-19 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021518-002 VESICARE 10MG TABLET / ORAL AB RLD, RS 2004-11-19 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 78 observed states.
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021518-001 6017927*PED 2019-05-19 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021518-002 6017927*PED 2019-05-19 Pediatric extension 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N021518-001 6017927*PED 2019-05-19 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021518-002 6017927*PED 2019-05-19 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021518-001 6017927*PED 2019-05-19 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021518-002 6017927*PED 2019-05-19 Pediatric extension b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021518-001 6017927*PED 2019-05-19 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021518-002 6017927*PED 2019-05-19 Pediatric extension ea99ee380514…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 26 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 50090-0972 VESIcare solifenacin succinate A-S Medication Solutions NDA Current 51248-150 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-150 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-150 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-150 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-150 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-150 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-151 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-151 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-151 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-151 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-151 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 51248-151 VESIcare solifenacin succinate Astellas Pharma US, Inc. NDA Current 55154-3875 VESIcare solifenacin succinate Cardinal Health NDA Current 55154-3876 VESIcare solifenacin succinate Cardinal Health NDA Current 55154-3877 VESIcare solifenacin succinate Cardinal Health NDA Current 55154-3877 VESIcare solifenacin succinate Cardinal Health NDA Current 55154-3878 VESIcare solifenacin succinate Cardinal Health NDA Current 55154-3878 VESIcare solifenacin succinate Cardinal Health NDA Current 66993-397 Solifenacin Succinate solifenacin succinate Prasco NDA AUTHORIZED GENERIC Current 66993-398 Solifenacin Succinate solifenacin succinate Prasco NDA AUTHORIZED GENERIC Current 68151-5406 VESIcare solifenacin succinate Carilion Materials Management NDA Current 70518-1866 VESIcare solifenacin succinate REMEDYREPACK INC. NDA Current 70518-1866 VESIcare solifenacin succinate REMEDYREPACK INC. NDA Current 70518-1866 VESIcare solifenacin succinate REMEDYREPACK INC. NDA Current 70518-2094 VESIcare solifenacin succinate REMEDYREPACK INC. NDA Current